Acetylcholine and norepinephrine stimulate the release of corticotropin-releasing factor-41 from the rat hypothalamus in vitro.

The effects of the two putative neurotransmitters acetylcholine and norepinephrine on immunoreactive CRF-41 release from incubated rat hypothalami were studied. Acetylcholine at concentrations of 10(-11) to 10(-7) M stimulated CRF-41 release. This effect was blocked in a dose-dependent manner by the...

Full description

Bibliographic Details
Main Authors: Tsagarakis, S, Holly, J, Rees, L, Besser, G, Grossman, A
Format: Journal article
Language:English
Published: 1988
_version_ 1826262405160632320
author Tsagarakis, S
Holly, J
Rees, L
Besser, G
Grossman, A
author_facet Tsagarakis, S
Holly, J
Rees, L
Besser, G
Grossman, A
author_sort Tsagarakis, S
collection OXFORD
description The effects of the two putative neurotransmitters acetylcholine and norepinephrine on immunoreactive CRF-41 release from incubated rat hypothalami were studied. Acetylcholine at concentrations of 10(-11) to 10(-7) M stimulated CRF-41 release. This effect was blocked in a dose-dependent manner by the muscarinic antagonist atropine (10(-9) to (-7) M). The nicotinic antagonist hexamethonium was ineffective at a dose of 10(-7) M, but produced slight inhibition of this response at 10(-5) M. Norepinephrine at concentrations of 10(-10) to 10(-6) M also produced a dose-dependent stimulation of CRF-41 release. The beta-adrenoceptor antagonists propranolol (10(-5) M) and timolol (10(-6) M) blocked norepinephrine-induced CRF-41 release. The alpha 1-adrenoceptor antagonists thymoxamine (10(-5) M), prazosin (10(-5) M), and corynanthine (10(-4) M), and the alpha 2-antagonist idazoxan (10(-5) M), were ineffective. Potassium depolarization (56 mM) caused stimulation of CRF-41 release which was dependent on the presence of calcium in the incubation medium. Authenticity of immunoreactive CRF-41 released was demonstrated by chromatographic criteria using gel filtration and reversed phase HPLC. These results provide evidence for a stimulatory role of acetylcholine and norepinephrine on CRF-41 release, and consequently on hypothalamo-pituitary-adrenal axis in the rat, through actions at a hypothalamic level. The stimulatory effect of acetylcholine is mediated principally through muscarinic receptors and that of norepinephrine through beta-adrenoceptors.
first_indexed 2024-03-06T19:35:39Z
format Journal article
id oxford-uuid:1ef51312-e305-4fad-97a0-f33ff058de61
institution University of Oxford
language English
last_indexed 2024-03-06T19:35:39Z
publishDate 1988
record_format dspace
spelling oxford-uuid:1ef51312-e305-4fad-97a0-f33ff058de612022-03-26T11:19:07ZAcetylcholine and norepinephrine stimulate the release of corticotropin-releasing factor-41 from the rat hypothalamus in vitro.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:1ef51312-e305-4fad-97a0-f33ff058de61EnglishSymplectic Elements at Oxford1988Tsagarakis, SHolly, JRees, LBesser, GGrossman, AThe effects of the two putative neurotransmitters acetylcholine and norepinephrine on immunoreactive CRF-41 release from incubated rat hypothalami were studied. Acetylcholine at concentrations of 10(-11) to 10(-7) M stimulated CRF-41 release. This effect was blocked in a dose-dependent manner by the muscarinic antagonist atropine (10(-9) to (-7) M). The nicotinic antagonist hexamethonium was ineffective at a dose of 10(-7) M, but produced slight inhibition of this response at 10(-5) M. Norepinephrine at concentrations of 10(-10) to 10(-6) M also produced a dose-dependent stimulation of CRF-41 release. The beta-adrenoceptor antagonists propranolol (10(-5) M) and timolol (10(-6) M) blocked norepinephrine-induced CRF-41 release. The alpha 1-adrenoceptor antagonists thymoxamine (10(-5) M), prazosin (10(-5) M), and corynanthine (10(-4) M), and the alpha 2-antagonist idazoxan (10(-5) M), were ineffective. Potassium depolarization (56 mM) caused stimulation of CRF-41 release which was dependent on the presence of calcium in the incubation medium. Authenticity of immunoreactive CRF-41 released was demonstrated by chromatographic criteria using gel filtration and reversed phase HPLC. These results provide evidence for a stimulatory role of acetylcholine and norepinephrine on CRF-41 release, and consequently on hypothalamo-pituitary-adrenal axis in the rat, through actions at a hypothalamic level. The stimulatory effect of acetylcholine is mediated principally through muscarinic receptors and that of norepinephrine through beta-adrenoceptors.
spellingShingle Tsagarakis, S
Holly, J
Rees, L
Besser, G
Grossman, A
Acetylcholine and norepinephrine stimulate the release of corticotropin-releasing factor-41 from the rat hypothalamus in vitro.
title Acetylcholine and norepinephrine stimulate the release of corticotropin-releasing factor-41 from the rat hypothalamus in vitro.
title_full Acetylcholine and norepinephrine stimulate the release of corticotropin-releasing factor-41 from the rat hypothalamus in vitro.
title_fullStr Acetylcholine and norepinephrine stimulate the release of corticotropin-releasing factor-41 from the rat hypothalamus in vitro.
title_full_unstemmed Acetylcholine and norepinephrine stimulate the release of corticotropin-releasing factor-41 from the rat hypothalamus in vitro.
title_short Acetylcholine and norepinephrine stimulate the release of corticotropin-releasing factor-41 from the rat hypothalamus in vitro.
title_sort acetylcholine and norepinephrine stimulate the release of corticotropin releasing factor 41 from the rat hypothalamus in vitro
work_keys_str_mv AT tsagarakiss acetylcholineandnorepinephrinestimulatethereleaseofcorticotropinreleasingfactor41fromtherathypothalamusinvitro
AT hollyj acetylcholineandnorepinephrinestimulatethereleaseofcorticotropinreleasingfactor41fromtherathypothalamusinvitro
AT reesl acetylcholineandnorepinephrinestimulatethereleaseofcorticotropinreleasingfactor41fromtherathypothalamusinvitro
AT besserg acetylcholineandnorepinephrinestimulatethereleaseofcorticotropinreleasingfactor41fromtherathypothalamusinvitro
AT grossmana acetylcholineandnorepinephrinestimulatethereleaseofcorticotropinreleasingfactor41fromtherathypothalamusinvitro